Search research articles
Contact Us
Filters
Showing results (21-30 of 290) with videos related to
Page
of 29
Sort By:
Cancer Genetics
|
December 12, 2012
The Pro/Pro genotype at TP53 codon 72 polymorphism is associated with early onset glioblastoma
Soufiane El Hallani, Marta Rossetto, Marc Sanson
Current Opinion in Oncology
|
January 1, 2005
Molecular changes in gliomas
Marc Sanson, Joëlle Thillet, Khê Hoang-Xuan
Current Opinion in Oncology
|
September 22, 2006
Molecular changes in brain tumors: prognostic and therapeutic impact
Marc Sanson, Florence Laigle-Donadey, Alexandra Benouaich-Amiel
Current Opinion in Neurology
|
September 22, 2018
Current and future tools for determination and monitoring of isocitrate dehydrogenase status in gliomas
Alberto Picca, Anna L Di Stefano, Marc Sanson
Bulletin Du Cancer
|
June 11, 2008
[Systemic metastases of malignant gliomas]
Maryam Fourtassi, Dimitri Psimaras, François Ducray, et al.
The Oncologist
|
February 6, 2010
IDH1 gene mutations: a new paradigm in glioma prognosis and therapy?
Marianne Labussiere, Marc Sanson, Ahmed Idbaih, et al.
Bulletin Du Cancer
|
May 13, 2005
[Towards a molecular classification of gliomas]
Khê Hoang-Xuan, Ahmed Idbaih, Karima Mokhtari, et al.
Neurology
|
January 15, 2003
Dramatic response to chemotherapy in oligodendroglial gliomatosis cerebri
Elie Louis, Florence Keime-Guibert, Jean-Yves Delattre, et al.
Presse Medicale (Paris, France : 1983)
|
July 6, 2014
[Acute demyelination secondary to radiation therapy in a patient with glioma]
Ouologuem Madani, Flavie Bompaire, Karima Mokhtari, et al.
Acta Neurochirurgica
|
August 1, 2014
Successful treatment of multiple intracranial meningiomas with the antiprogesterone receptor agent mifepristone (RU486)
Mehdi Touat, Giuseppe Lombardi, Patrizia Farina, et al.
Page
of 29
Search research articles
Search
Showing results (21-30 of 290) with videos related to
Sort By:
Page
of 29
Cancer Genetics
|
December 12, 2012
The Pro/Pro genotype at TP53 codon 72 polymorphism is associated with early onset glioblastoma
Soufiane El Hallani, Marta Rossetto, Marc Sanson
Current Opinion in Oncology
|
January 1, 2005
Molecular changes in gliomas
Marc Sanson, Joëlle Thillet, Khê Hoang-Xuan
Current Opinion in Oncology
|
September 22, 2006
Molecular changes in brain tumors: prognostic and therapeutic impact
Marc Sanson, Florence Laigle-Donadey, Alexandra Benouaich-Amiel
Current Opinion in Neurology
|
September 22, 2018
Current and future tools for determination and monitoring of isocitrate dehydrogenase status in gliomas
Alberto Picca, Anna L Di Stefano, Marc Sanson
Bulletin Du Cancer
|
June 11, 2008
[Systemic metastases of malignant gliomas]
Maryam Fourtassi, Dimitri Psimaras, François Ducray, et al.
The Oncologist
|
February 6, 2010
IDH1 gene mutations: a new paradigm in glioma prognosis and therapy?
Marianne Labussiere, Marc Sanson, Ahmed Idbaih, et al.
Bulletin Du Cancer
|
May 13, 2005
[Towards a molecular classification of gliomas]
Khê Hoang-Xuan, Ahmed Idbaih, Karima Mokhtari, et al.
Neurology
|
January 15, 2003
Dramatic response to chemotherapy in oligodendroglial gliomatosis cerebri
Elie Louis, Florence Keime-Guibert, Jean-Yves Delattre, et al.
Presse Medicale (Paris, France : 1983)
|
July 6, 2014
[Acute demyelination secondary to radiation therapy in a patient with glioma]
Ouologuem Madani, Flavie Bompaire, Karima Mokhtari, et al.
Acta Neurochirurgica
|
August 1, 2014
Successful treatment of multiple intracranial meningiomas with the antiprogesterone receptor agent mifepristone (RU486)
Mehdi Touat, Giuseppe Lombardi, Patrizia Farina, et al.
Page
of 29